yourstory.com /1 month ago

SELUTION SLR™ wins historic US FDA nod for in‑stent restenosis

SELUTION SLR™ wins historic US FDA nod for in‑stent restenosis The US Food and Drug Administration has approved the SELUTION SLR™ (Sustained Limus Release) Drug-Eluting Bal...

Read source
drugs.com /5 days ago

New Pill Combo, Wilserdly + Everolimus, Approved For Breast Cancer That Stops Responding To Hormone Therapy

TUESDAY, Nov. 17, 2026 — People with advanced breast cancer that has stopped responding to hormone therapy now have a new pill-based treatment option. The U.S. Food and Drug Admini...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.